Coloplast A/S (OTCMKTS:CLPBY) Hits New 1-Year Low – Here’s What Happened

Shares of Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) hit a new 52-week low during mid-day trading on Monday . The stock traded as low as $7.71 and last traded at $7.72, with a volume of 21594 shares. The stock had previously closed at $7.81.

Wall Street Analysts Forecast Growth

Separately, Sanford C. Bernstein raised shares of Coloplast A/S to a “hold” rating in a research note on Wednesday, January 28th. Three research analysts have rated the stock with a Hold rating, Based on data from MarketBeat, the stock has a consensus rating of “Hold”.

Coloplast A/S Price Performance

The stock has a market cap of $17.26 billion, a P/E ratio of 28.37, a PEG ratio of 0.77 and a beta of 0.26. The company has a quick ratio of 1.00, a current ratio of 1.61 and a debt-to-equity ratio of 1.20. The firm’s fifty day moving average price is $8.64 and its 200-day moving average price is $9.07.

Coloplast A/S (OTCMKTS:CLPBY) last posted its earnings results on Friday, February 6th. The company reported $0.10 earnings per share for the quarter, topping analysts’ consensus estimates of $0.09 by $0.01. The company had revenue of $1.11 billion during the quarter, compared to analyst estimates of $1.12 billion. Coloplast A/S had a net margin of 14.35% and a return on equity of 27.08%. Analysts forecast that Coloplast A/S Sponsored ADR will post 0.31 earnings per share for the current year.

Coloplast A/S Company Profile

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.